INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹251 Cr | ₹256 Cr | ₹205 Cr | ₹194 Cr | ₹88 Cr |
What is the latest Total Non-Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹251 Cr |
| Mar2025 | ₹256 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹88 Cr |
How is Total Non-Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹251 Cr | -2.02 | |
| Mar2025 | ₹256 Cr | 25.03 | |
| Mar2024 | ₹205 Cr | 5.35 | |
| Mar2023 | ₹194 Cr | 120.40 | |
| Mar2022 | ₹88 Cr | - | |
Compare Total Non-Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹5,602.2 Cr | -1.9% | 4.5% | 10.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -1.9% |
4.5% |
10.1% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses